In order to further explore whether c-MYC manipulated glycolytic metabolism through SULT2B1 to affect the proliferation and chemoresistance of colon cancer cells, we successfully constructed a cell line with c-MYC knockdown and SULT2B1 overexpression (Fig. 5A). This evidence concerns the gene SULT2B1 and colonic neoplasm.